Therapeutic Advances In Medical Oncology

Therapeutic Advances In Medical Oncology

医学肿瘤学的治疗进展

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Therapeutic Advances In Medical Oncology》是由SAGE Publications Inc.出版社于2009年创办的英文国际期刊(ISSN: 1758-8340,E-ISSN: 1758-8359),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比76.40%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在267篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Therapeutic Advances In Medical Oncology审稿周期约为15 Weeks。该刊近年未被列入国际预警名单,年发文量约267篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 267 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 111 / 333

66.8

学科:ONCOLOGY SCIE Q2 142 / 333

57.51

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 88 / 322

72.8

学科:ONCOLOGY SCIE Q2 113 / 322

65.06

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.2 SJR:1.416 SNIP:1.07
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 100 / 428

76%

期刊发文

  • Low-level HBV viremia independently predicts poor outcomes in patients with intermediate-to-advanced HBV-related hepatocellular carcinoma receiving systemic therapy: a multicenter retrospective stud

    Author: Lei, Jin; Ma, Huaxing; Chen, Xiong; Lin, Ling; Liang, Zhipeng; Ou, Guangling; Jin, Jiliang; Dai, Hongyuan; Zhang, Ya; Liu, Mei; Li, Haiyang; Lu, Yinying

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261435330

  • Treatment patterns and clinical outcomes of neoadjuvant chemoimmunotherapy for patients with resected oesophageal squamous cell carcinoma: a Chinese multicentre retrospective stud

    Author: Yu, Xiangyang; Zhu, Jianfei; Wang, Feng; Ma, Kai; Guo, Xiaotong; Zhang, Baihua; Wang, Lixu; Yu, Xin; Lin, Shengcheng; Ng, Calvin S. H.; Yang, Ran; He, Jie; Yu, Zhentao

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261443147

  • S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cance

    Author: Maimaiti, Yilizhati; Chen, Yulian; Li, Longxia; Cai, Meichun; Li, Zeyun; Lin, Lifeng; Gao, Shangbing; Zhuang, Guanglei; Wu, Wei; Zang, Rongyu

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261436959

  • A real-world study on the comparative effectiveness of first-line treatment regimens in advanced NSCLC patients with PACC mutation

    Author: Liu, Dujiang; Li, Xinyue; Yin, Kailai; Lu, Yi; Han, Na; Xu, Yanjun

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261442625

  • Comparative effectiveness of first-line taxane-platinum versus fluorouracil-platinum chemotherapy in advanced esophageal squamous cell carcinoma: a propensity score-matched real-world stud

    Author: Ye, Sisi; Li, Chao; Liu, Rongrui; Zhao, Chuanhua; Li, Juan; Xu, Jianming

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261436621

  • Anti-PD-1 matches interferon as adjuvant therapy for acral melanoma: a retrospective stud

    Author: Du, Yu; Chen, Yu; Wang, Jiaxiang; Lin, Jing; Wei, Xiaoting; Gu, Junjie; Guo, Jun; Si, Lu; Mao, Lili

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261436189

  • Integrating intracranial hypofractionated radiotherapy with immunotherapy for melanoma brain metastases: therapeutic impact and immune modulatio

    Author: Lin, Jing; Zhang, Ting; Zeng, Yibin; Tang, Lirui; Cai, Jieyuan; Chen, Ling; Fang, Jiazhen; Chen, Yu; Li, Jinluan

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261444616

  • The relationship between genetic mutations and organ metastasis in non-small cell lung cance

    Author: Xue, Haiying; Chen, Yuzhu; Qi, Fei; Chen, Kaixuan; Liu, Xiaolin; Zhang, Muxin; Gao, Ziyuan; Cai, Shanshan; Gao, Tianbo; Zhang, Tongmei

    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2026; Vol. 18, Issue , pp. -. DOI: 10.1177/17588359261424770